Compare BioNano Genomics Inc (BNGO) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Suncor Energy Inc. — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while Suncor Energy Inc. trades at $63.77 (market cap $74.07B). The key difference: Suncor Energy Inc. is far larger — about 5422.4× BioNano Genomics Inc's market cap, and Suncor Energy Inc. pays a 2.7% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | SU | |
|---|---|---|
Market Cap | $13.66M | $74.07B |
Sector | Health | Energy |
52-Week High | $4.92 | $69.73 |
52-Week Low | $1.06 | $38.17 |
Enterprise Value | $16.26M | $80.75B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
Suncor Energy (SU) trades at $63.82, up 1.74% with neutral technical signals. The company shows strong fundamentals with a P/E of 11.79, ROE of 19.25%, and consistent dividend payments. Recent Q2 2026 earnings beat expectations at $2.27 per share versus $2.14 expected, driven by strong downstream operations despite weather challenges. Analyst consensus is strongly bullish with 74% buy ratings.
SU presents a compelling value opportunity with attractive valuation metrics and strong profitability. Key risks include commodity price volatility and operational challenges from weather disruptions. The upcoming CEO transition in 2027 adds leadership uncertainty, but current cash flow strength supports shareholder returns through buybacks and dividends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
